Upload

Loading...

GRACEcast-110_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Socinski on Single Agent vs Doublet Chemo

29 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 19, 2012

http://cancerGRACE.org/

Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...